# Emerging Longevity Ventures

> Emerging Longevity Ventures is a VC fund backing Biotechnology and Health Care. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Jul 2024
- Lead investor: 17%
- Last updated: Aug 2026
- Website: http://www.emerginglongevityventures.com/

Emerging Longevity Ventures is a venture capital firm.

## Contacts

5 contacts available for Emerging Longevity Ventures. Shizune tracks 1 team members at Emerging Longevity Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/emerging-longevity-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 50% |
| Health Care | 2 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Funding Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 1 | 17% |
| United Kingdom | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Brian Manning Delaney | Founder | 2 | https://shizune.co/investors/profile/brian-manning-delaney |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ImmuneAGE Bio | ImmuneAGE Bio is an intriguing initiative focused on drug discovery for immune system rejuvenation. Developing therapies that can rejuvenate or enhance the immune system could have profound implications for healthcare, especially in aging populations or those with compromised immune function | $2M | Seed | Jul 11, 2024 |  |
| Senisca | Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing. | $4.8M |  | Mar 18, 2024 |  |
| Senisca | Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing. | $4.7M | Seed | Mar 18, 2024 |  |
| Senisca | Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing. | $2.5M | Seed | Jun 09, 2022 |  |
| Senisca | Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing. | $1.8M | Seed | Mar 05, 2021 |  |
| Repair Biotechnologies | Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling humanbeings to improve their health span through targeting the causes of age-related diseases and ageing itself. | $2.2M | Seed | May 07, 2019 |  |

6 of 6 investments shown.

## Co-investors
- [QantX](https://shizune.co/investors/profile/qantx) — VC Fund, 5 deals together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-2) — VC Fund, 4 deals together
- [R42 Group](https://shizune.co/investors/profile/r42-group) — VC Fund, 4 deals together
- [Trend Investment Group](https://shizune.co/investors/profile/trend-investment-group) — VC Fund, 4 deals together
- [Lifespan Vision Ventures](https://shizune.co/investors/profile/lifespan-vision-ventures) — VC Fund, 3 deals together
- [APEX Ventures](https://shizune.co/investors/profile/apex-ventures-12df) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Emerging Longevity Ventures invest in?

Emerging Longevity Ventures invests primarily in Biotechnology and Health Care startups, most often at Seed and Funding Round stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Emerging Longevity Ventures?

Public channels for Emerging Longevity Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Emerging Longevity Ventures?

The team at Emerging Longevity Ventures includes Brian Manning Delaney (Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co